Clinical Trials

91 enrolled

BreastGenitourinary

Breast Neoplasms, Carcinoma, Renal Cell, Triple Negative Breast Neoplasms

NCT03567720 2023-06-01

Tavo and Pembrolizumab With or Without Chemotherapy in Patients With Inoperable Locally Advanced or Metastatic TNBC

65 enrolled

Neoplasm Metastasis, Triple Negative Breast Neoplasms

NCT05828381 2023-04-25

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

33 enrolled

Esophageal Neoplasms

NCT04338620 2023-03-06

Camrelizumab Combined With Albumin-bound Paclitaxel and Platinum in Neoadjuvant Treatment of Resectable NSCLC

94 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05633914 2023-02-21

Tucidinostat and Nab-paclitaxel in Advanced HR+/HER2- Breast Cancer

90 enrolled

HR+/HER2- Breast Cancer

NCT05669807 2023-01-03

Camrelizumab Combined With Irinotecan or Albumin Paclitaxel for Second-line Treatment of Advanced Gastric Cancer

184 enrolled

Second Line Treatment of Gastric Cancer

NCT05640791 2022-12-07

Durvalumab Combined With Chemotherapy Neoadjuvant Therapy of Biliary Tract Cancer

Resectable Biliary Tract Cancer

NCT04917900 2022-10-10

Single-arm, Multi-center Clinical Study of Pyrotinib Maleate Tablets Combined With Albumin-bound Paclitaxel and Trastuzumab in Neoadjuvant Treatment of Her2-positive Early or Locally Advanced Breast Cancer

216 enrolled

Breast Neoplasms

NCT05552651 2022-09-23

Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Esophageal Squamous Cell Carcinoma

NCT03487016 2022-09-08

FOOTPATH

270 enrolled

Neoplasm Metastasis, Pancreatic Neoplasms

NCT04459611 2022-07-12

neoSCORE

60 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05322720 2022-04-12

HR Positive, HER2 Negative Advanced Breast Cancer With Progression After Endocrine Therapy

50 enrolled

Breast Neoplasms

NCT04876313 2022-04-06

NURE-Combo

29 enrolled

Muscle-Invasive Bladder Carcinoma

NCT05310344 2022-04-04

Albumin-bound Paclitaxel and Bevacizumab for Platinum-resistant Recurrent Ovarian Cancer

50 enrolled

Ovarian Neoplasms

NCT05290935 2022-03-22

Immunotherapy for Recurrent Cervical Cancer Refractory to Platinum-based Chemotherapy: Multi-Center Trial

122 enrolled

Uterine Cervical Neoplasms

NCT05007145 2021-12-21

REVO

92 enrolled

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT04089150 2021-10-22

MASTERPLAN

120 enrolled

Pancreatic Neoplasms

NCT04725448 2021-04-06

Toripalimab Combined With Bevacizumab, Nab-paclitaxel and Carboplatin for Untreated Metastatic Pulmonary Sarcomatoid Carcinoma

27 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Diseases, Thoracic Neoplasms

NCT04815408 2021-03-25

PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer

Ovarian Neoplasms

NCT04780347 2021-03-03

Albumin-bound Paclitaxel Combination With Capecitabine Versus Capecitabine Monotherapy in Paclitaxel/Docetaxel-resistant Advanced Breast Cancer

92 enrolled

Breast Neoplasms

NCT04681911 2020-12-23

Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer

71 enrolled

Breast Neoplasms

NCT04639271 2020-11-20

Pyrotinib, Trastuzumab And Abraxane in HER2-positive MBC With Brain Metastasis

100 enrolled

Breast Neoplasms

NCT04602013 2020-10-26

Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

53 enrolled

Esophageal Squamous Cell Carcinoma

NCT04590625 2020-10-19

Apatinib Combined With Abraxane and Carboplatin or Cisplatinum as First-line Treatment for Epithelial Ovarian Cancer

58 enrolled

Ovarian Neoplasms

NCT04216758 2020-06-30

Nab-P and Gem Compared With Gem and Tegafur in Adjuvant Chemotherapy After Radical Resection of Pancreatic Cancer

300 enrolled

Stage IA Pancreatic Adenocarcinoma

NCT04177875 2019-11-26

T+TP

44 enrolled

Esophageal Neoplasms

NCT04056949 2019-08-14

Efficacy and Safety of IBI308 and Paclitaxel/Albumin Paclitaxel for SCLC Patients Who Failed Etoposide Chemotherapy

Small Cell Lung Carcinoma

NCT03942068 2019-05-08

Apatinib With Albumin-bound Paclitaxel in Patients With Platinum-resistant Recurrent Ovarian Cancer

35 enrolled

Ovarian Neoplasms

NCT03825328 2019-01-31

A Trial of NS/GEMOX Chemotherapy in Patients With Untreated Pancreatic Cancer ( HZ-NS/GEMOX-PC )

Pancreatic Neoplasms

NCT03636308 2018-08-17

ASAGPAC

Pancreatic Neoplasms

NCT03219762 2017-07-26

Nabster

65 enrolled

Small Cell Lung Carcinoma

NCT01830244 2017-07-02

Neonab

60 enrolled

Pathologic Complete Response, Breast Neoplasms

NCT01964534 2017-01-31

AFUGEM

114 enrolled

Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT02124317 2016-12-22

NAPSPAC

60 enrolled

Advanced Pancreatic Cancer

NCT01494415 2015-12-15

Concurrent Nab-P/Carboplatin and Thoracic Radiotherapy in Squamous Cell Lung Cancer

21 enrolled

Carcinoma, Non-Small-Cell Lung, Carcinoma, Squamous Cell

NCT02262897 2014-10-13

The Efficacy and Safety of Nab-paclitaxel in Pretreated Patients With Extensive Disease of Small Cell Lung Cancer

Small Cell Lung Carcinoma

NCT02229045 2014-08-29

Phase II Study of Albumin Bound Paclitaxel With 5-FU and CF as Second Line in Taxanes Naive Advanced Gastric Cancer

37 enrolled

Gastric Caner

NCT02142335 2014-05-20

Rituxan and Abraxane for the Treatment of Patients With Inoperable Stage III and IV Malignant Melanoma

17 enrolled

Dermatologic

Melanoma

NCT02135822 2014-05-16

NAPGAP

Advanced Pancreatic Cancer

NCT01969955 2014-04-25

Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer

50 enrolled

Squamous Cell Carcinoma of Lung

NCT01625429 2012-11-09

Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer

Breast Neoplasms

NCT01667211 2012-08-22

CSAPPPCC